GSK’s (GSK) Buy Rating Reiterated at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft reaffirmed their buy rating on shares of GSK (LON:GSK) in a research report report published on Friday morning, MarketBeat reports. They currently have a GBX 1,950 ($24.74) target price on the stock.

GSK has been the subject of a number of other research reports. Shore Capital reissued a buy rating on shares of GSK in a research report on Thursday. Citigroup restated a buy rating and set a GBX 2,100 ($26.64) target price on shares of GSK in a research note on Monday, June 24th. JPMorgan Chase & Co. reaffirmed an underweight rating on shares of GSK in a research report on Tuesday, June 18th. Barclays reissued an equal weight rating and issued a GBX 1,725 ($21.88) price objective on shares of GSK in a research report on Tuesday, May 7th. Finally, Jefferies Financial Group reaffirmed a buy rating and set a GBX 2,100 ($26.64) target price on shares of GSK in a research report on Thursday. One analyst has rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, GSK has an average rating of Moderate Buy and a consensus target price of GBX 1,791.25 ($22.72).

GSK Trading Up 0.2 %

LON:GSK opened at GBX 1,529.50 ($19.40) on Friday. The company has a quick ratio of 0.73, a current ratio of 0.87 and a debt-to-equity ratio of 134.34. The company’s 50 day moving average is GBX 1,685.84 and its 200-day moving average is GBX 1,632.29. The firm has a market cap of £62.40 billion, a price-to-earnings ratio of 1,403.21, a P/E/G ratio of 1.19 and a beta of 0.27. GSK has a 12 month low of GBX 1,302.60 ($16.52) and a 12 month high of GBX 1,823.50 ($23.13).

GSK Cuts Dividend

The company also recently announced a dividend, which will be paid on Thursday, July 11th. Investors of record on Thursday, May 16th will be paid a GBX 15 ($0.19) dividend. The ex-dividend date of this dividend is Thursday, May 16th. This represents a dividend yield of 0.9%. GSK’s payout ratio is 5,504.59%.

Insider Buying and Selling

In other GSK news, insider Wendy Becker purchased 446 shares of the stock in a transaction on Thursday, June 20th. The shares were purchased at an average price of GBX 1,614 ($20.47) per share, with a total value of £7,198.44 ($9,131.60). 1.60% of the stock is owned by company insiders.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.